跳至主要内容
临床试验/JPRN-UMIN000013014
JPRN-UMIN000013014已完成未知

Preventive effects with teriparatide or alendronate on the progression of vertebral collapse - T-WRAP (Teriparatide for new vertebral fractures to wedge deformity prevention study)

Kitakyushu Osteoporosis Trial Unit0 个研究点目标入组 200 人开始时间: 2014年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1. Patients with vertebral compression fractures which is not clear the time of injury. 2. Patients received teriparatide or denosumab within 6 months prior to the study. 3. Patients with contraindications of teriparatide or alendronate. 4. Patients with severe renal dysfunction, severe liver dysfunction, or severe heart disease. 5. Inappropriate patients to participate the study judged by primary physician.

研究者

发起方
Kitakyushu Osteoporosis Trial Unit

相似试验

已完成
2 期
Effect of Teriparatide, Alendronate, and Zoledronic Acid on treatment of secondary osteoporosisSecondary osteoporosis.Osteoporosis with pathological fracture
IRCT201605159014N98Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences120
进行中(未招募)
不适用
Comparison of the Effects of Teriparatide with those of Risendronate on Lumbar Spine Volumetric Bone Mineral Density in GLucocorticpid-Induced Osteoporosis in Men - GHDH
EUCTR2006-006315-68-DEEli Lilly and Company Limited104
进行中(未招募)
1 期
Comparison of the Effects of Teriparatide with those of Risedronate on Lumbar Spine Bone Mineral Density in Men and Postmenopausal Women with Low Bone Mass and a Recent Pertrochanteric Hip FracturePostmenopausal Women and Men with Low Bone Mass and a Recent Pertrochanteric FractureMedDRA version: 17.1Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2008-002693-35-DKEli Lilly and Company Ltd220
进行中(未招募)
不适用
Comparison of the Effects of Teriparatide with those of Risedronate on Lumbar Spine Volumetric Bone Mineral Density in Glucocorticoid-Induced Osteoporosis in Men - ND
EUCTR2006-006315-68-ITEli Lilly and Company104
进行中(未招募)
1 期
Comparison of Teriparatide with Risedronate on Lumbar Spine Bone Mineral Density in Men and Postmenopausal Women with Low Bone Mass and a Recent Pertrochanteric Hip FracturePostmenopausal Women and Men with Low Bone Mass and a Recent Pertrochanteric FractureMedDRA version: 17.1Level: LLTClassification code 10031288Term: Osteoporosis with fractureSystem Organ Class: 100000004859
EUCTR2008-002693-35-SEEli Lilly and Company Ltd285